4.4 Article

Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement

期刊

ARTHRITIS CARE & RESEARCH
卷 68, 期 12, 页码 1866-1873

出版社

WILEY-BLACKWELL
DOI: 10.1002/acr.23089

关键词

-

资金

  1. American College of Rheumatology
  2. Robert L. Kroc Chair in Rheumatic and Connective Tissue Diseases (I) [AHRQ-R01-HS024412]
  3. Russell/Engleman Medical Research Center for Arthritis
  4. Pfizer

向作者/读者索取更多资源

Objective. The Rheumatology Informatics System for Effectiveness (RISE) is a national electronic health record (EHR)enabled registry. RISE passively collects data from EHRs of participating practices, provides advanced quality measurement and data analytic capacities, and fulfills national quality reporting requirements. Here we report the registry's architecture and initial data, and we demonstrate how RISE is being used to improve the quality of care. Methods. RISE is a certified Centers for Medicare and Medicaid Services Qualified Clinical Data Registry, allowing collection of data without individual patient informed consent. We analyzed data between October 1, 2014 and September 30, 2015 to characterize initial practices and patients captured in RISE. We also analyzed medication use among rheumatoid arthritis (RA) patients and performance on several quality measures. Results. Across 55 sites, 312 clinicians contributed data to RISE; 72% were in group practice, 21% in solo practice, and 7% were part of a larger health system. Sites contributed data on 239,302 individuals. Among the subset with RA, 34.4% of patients were taking a biologic or targeted synthetic disease-modifying antirheumatic drug (DMARD) at their last encounter, and 66.7% were receiving a nonbiologic DMARD. Examples of quality measures include that 55.2% had a disease activity score recorded, 53.6% a functional status score, and 91.0% were taking a DMARD in the last year. Conclusion. RISE provides critical infrastructure for improving the quality of care in rheumatology and is a unique data source to generate new knowledge. Data validation and mapping are ongoing and RISE is available to the research and clinical communities to advance rheumatology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据